These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 36504783)

  • 1. Efficacy of finafloxacin in a murine model of inhalational glanders.
    Barnes KB; Bayliss M; Davies C; Richards MI; Laws TR; Vente A; Harding SV
    Front Microbiol; 2022; 13():1057202. PubMed ID: 36504783
    [No Abstract]   [Full Text] [Related]  

  • 2. Trimethoprim/sulfamethoxazole (co-trimoxazole) prophylaxis is effective against acute murine inhalational melioidosis and glanders.
    Barnes KB; Steward J; Thwaite JE; Lever MS; Davies CH; Armstrong SJ; Laws TR; Roughley N; Harding SV; Atkins TP; Simpson AJ; Atkins HS
    Int J Antimicrob Agents; 2013 Jun; 41(6):552-7. PubMed ID: 23517714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Demonstrating the Protective Efficacy of the Novel Fluoroquinolone Finafloxacin against an Inhalational Exposure to Burkholderia pseudomallei.
    Barnes KB; Hamblin KA; Richards MI; Laws TR; Vente A; Atkins HS; Harding SV
    Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28438936
    [No Abstract]   [Full Text] [Related]  

  • 4. Pre- and post-exposure prophylaxis of experimental Burkholderia pseudomallei infection with doxycycline, amoxicillin/clavulanic acid and co-trimoxazole.
    Sivalingam SP; Sim SH; Jasper LC; Wang D; Liu Y; Ooi EE
    J Antimicrob Chemother; 2008 Mar; 61(3):674-8. PubMed ID: 18192684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Investigation into the Re-Emergence of Disease Following Cessation of Antibiotic Treatment in Balb/c Mice Infected with Inhalational
    Laws TR; Barnes KB; Jenner DC; Núñez A; Richards MI; Thwaite JE; Vente A; Rushton D; Nelson M; Harding SV
    Antibiotics (Basel); 2022 Oct; 11(10):. PubMed ID: 36290100
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of Burkholderia mallei ΔtonB Δhcp1 (CLH001) as a live attenuated vaccine in murine models of glanders and melioidosis.
    Khakhum N; Bharaj P; Myers JN; Tapia D; Walker DH; Endsley JJ; Torres AG
    PLoS Negl Trop Dis; 2019 Jul; 13(7):e0007578. PubMed ID: 31306423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Workshop on treatment of and postexposure prophylaxis for Burkholderia pseudomallei and B. mallei Infection, 2010.
    Lipsitz R; Garges S; Aurigemma R; Baccam P; Blaney DD; Cheng AC; Currie BJ; Dance D; Gee JE; Larsen J; Limmathurotsakul D; Morrow MG; Norton R; O'Mara E; Peacock SJ; Pesik N; Rogers LP; Schweizer HP; Steinmetz I; Tan G; Tan P; Wiersinga WJ; Wuthiekanun V; Smith TL
    Emerg Infect Dis; 2012 Dec; 18(12):e2. PubMed ID: 23171644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant Salmonella Expressing Burkholderia mallei LPS O Antigen Provides Protection in a Murine Model of Melioidosis and Glanders.
    Moustafa DA; Scarff JM; Garcia PP; Cassidy SK; DiGiandomenico A; Waag DM; Inzana TJ; Goldberg JB
    PLoS One; 2015; 10(7):e0132032. PubMed ID: 26148026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of a combination therapy approach for the treatment of melioidosis.
    Barnes KB; Richards MI; Burgess G; Armstrong SJ; Bentley C; Maishman TC; Laws TR; Nelson M; Harding SV
    Front Microbiol; 2022; 13():934312. PubMed ID: 36051754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of three non-human primate aerosol models for glanders, caused by Burkholderia mallei.
    Waag DM; Chance TB; Trevino SR; Rossi FD; Fetterer DP; Amemiya K; Dankmeyer JL; Ingavale SS; Tobery SA; Zeng X; Kern SJ; Worsham PL; Cote CK; Welkos SL
    Microb Pathog; 2021 Jun; 155():104919. PubMed ID: 33915206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of a safe, reproducible, and rapid aerosol delivery method to study infection by Burkholderia pseudomallei and Burkholderia mallei in mice.
    Lafontaine ER; Zimmerman SM; Shaffer TL; Michel F; Gao X; Hogan RJ
    PLoS One; 2013; 8(10):e76804. PubMed ID: 24098563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective efficacy of heat-inactivated B. thailandensis, B. mallei or B. pseudomallei against experimental melioidosis and glanders.
    Sarkar-Tyson M; Smither SJ; Harding SV; Atkins TP; Titball RW
    Vaccine; 2009 Jul; 27(33):4447-51. PubMed ID: 19490962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the Burkholderia mallei tonB Mutant and Its Potential as a Backbone Strain for Vaccine Development.
    Mott TM; Vijayakumar S; Sbrana E; Endsley JJ; Torres AG
    PLoS Negl Trop Dis; 2015; 9(6):e0003863. PubMed ID: 26114445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using real-time PCR to specifically detect Burkholderia mallei.
    Ulrich MP; Norwood DA; Christensen DR; Ulrich RL
    J Med Microbiol; 2006 May; 55(Pt 5):551-559. PubMed ID: 16585642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic Characterization of a Novel Virulence-Factor Deletion Strain of Burkholderia mallei That Provides Partial Protection against Inhalational Glanders in Mice.
    Bozue JA; Chaudhury S; Amemiya K; Chua J; Cote CK; Toothman RG; Dankmeyer JL; Klimko CP; Wilhelmsen CL; Raymond JW; Zavaljevski N; Reifman J; Wallqvist A
    Front Cell Infect Microbiol; 2016; 6():21. PubMed ID: 26955620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An increase in intracellular p62/NBR1 and persistence of Burkholderia mallei and B. pseudomallei in infected mice linked to autophagy deficiency.
    Saikh KU; Dankmeyer JL; Zeng X; Ulrich RG; Amemiya K
    Immun Inflamm Dis; 2019 Mar; 7(1):7-21. PubMed ID: 30569531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of Burkholderia mallei and pseudomallei vaccines.
    Silva EB; Dow SW
    Front Cell Infect Microbiol; 2013; 3():10. PubMed ID: 23508691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The autotransporter protein BatA is a protective antigen against lethal aerosol infection with
    Lafontaine ER; Chen Z; Huertas-Diaz MC; Dyke JS; Jelesijevic TP; Michel F; Hogan RJ; He B
    Vaccine X; 2019 Apr; 1():100002. PubMed ID: 33826684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection of non-human primates against glanders with a gold nanoparticle glycoconjugate vaccine.
    Torres AG; Gregory AE; Hatcher CL; Vinet-Oliphant H; Morici LA; Titball RW; Roy CJ
    Vaccine; 2015 Jan; 33(5):686-92. PubMed ID: 25533326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of efficacy of ciprofloxacin and doxycycline against experimental melioidosis and glanders.
    Russell P; Eley SM; Ellis J; Green M; Bell DL; Kenny DJ; Titball RW
    J Antimicrob Chemother; 2000 Jun; 45(6):813-8. PubMed ID: 10837435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.